Results for tag: "Renal Tubular Acidosis Drug"

Renal Tubular Acidosis (RTA) is a disorder of the kidneys that affects the body's ability to regulate acid-base balance. It is caused by a defect in the tubules of the kidneys, which are responsible for reabsorbing bicarbonate and excreting hydrogen ions. This results in an accumulation of acid in the blood, leading to a variety of symptoms. Treatment for RTA typically involves the use of medications to correct the acid-base imbalance, as well as dietary modifications to reduce the amount of acid in the diet. Liver and Kidney Disorders Drugs are used to treat a variety of conditions, including RTA. These drugs are designed to reduce the amount of acid in the blood, as well as to improve the function of the kidneys and liver. Commonly used drugs for RTA include sodium bicarbonate, potassium citrate, and thiazide diuretics. These drugs are often used in combination with dietary modifications to reduce the amount of acid in the diet. Companies in the Renal Tubular Acidosis Drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more